OSLO, Norway, Feb. 27, 2026 /PRNewswire/ -- Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces that its partner Asieris Pharmaceuticals (SSE: 688176) communicated today that its marketing authorization application (MAA) for Cevira® (APL-1702) for the treatment of high-grade...
Hence then, the article about photocure partner asieris announces that ema has accepted marketing authorization application for cevira in europe was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Photocure partner Asieris announces that EMA has accepted Marketing Authorization Application for CEVIRA in Europe )
Also on site :
- 1989 Phil Collins Single, the 'Worst Song Ever About Homelessness,' Became the Last No. 1 Hit of the '80s
- Ana Luisa’s ‘Dainty’ Crystal Huggie Earrings Capture the Essence of ‘Minimalist Chic,’ Now on Sale at Nordstrom
- Eightco Holdings (NASDAQ: ORBS) rende noto un portafoglio complessivo di circa 378 milioni di dollari, che comprende OpenAI, Beast Industries, oltre 16.000 ETH e quasi 302 milioni di token WLD